These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12577748)

  • 1. [Fear of the injection must not be an argument. Every second type 2 diabetic patient needs insulin].
    MMW Fortschr Med; 2002 Dec; 144(49):60. PubMed ID: 12577748
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
    Ravina A; Minuchin O
    Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combination therapy with insulin and sulfonylurea].
    Takamatsu J
    Nihon Rinsho; 1997 Nov; 55 Suppl():255-60. PubMed ID: 9434477
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination therapy with insulin and sulfonylurea].
    Takamatsu J
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():442-6. PubMed ID: 12387031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fear of long-term injections. Insulin therapy--soon treatment also without injection].
    MMW Fortschr Med; 2002 Jun; 144(23):8. PubMed ID: 12119913
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of diabetes mellitus].
    Kaneko T
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):406-9. PubMed ID: 8315336
    [No Abstract]   [Full Text] [Related]  

  • 7. [The rechargeable insulin injector, a beautiful evolution].
    Sauvanet JP
    Soins; 2007 Jun; (716):25-8. PubMed ID: 17718026
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
    Takamatsu J
    Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 10. Curbside consultation. Why can't this patient take insulin?
    Nymberg JH; Selby JW
    Am Fam Physician; 2000 Jan; 61(1):226, 228, 231. PubMed ID: 10643960
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy].
    Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A
    Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination therapy of oral hypoglycemic agents which enhance the efficacy of insulin therapy].
    Hirose T
    Nihon Rinsho; 2012 May; 70 Suppl 3():669-77. PubMed ID: 22768596
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy for NIDDM: has its time arrived?
    Menke J
    S D J Med; 1995 Aug; 48(8):246-7. PubMed ID: 7569874
    [No Abstract]   [Full Text] [Related]  

  • 15. Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes.
    Raskin P
    Diabetes Metab Res Rev; 2008; 24(1):3-13. PubMed ID: 17968971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of the treatment of type 2 diabetes with insulin glargine based on the LAPTOP trial.
    Janka HU; Högy B
    Eur J Health Econ; 2008 May; 9(2):165-70. PubMed ID: 17530309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
    Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
    Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination therapy insulin and sulfonylurea compounds. A critical analysis].
    Ratzmann KP; Berger M
    Z Arztl Fortbild (Jena); 1990; 84(21):1105-7. PubMed ID: 2281698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.